APO RESEARCH · REPORT
HEPES
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
Product & engineering
Understand the product.
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
Selected research
Market Structure
Global HEPES Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
North America is the largest market with about 56% market share. Europe is follower, accounting for about 27% market share.
The key players are Avantor, Thermo Fisher, Merck, Lonza, Cytiva, Promega Corporation, MP Biomedicals, Spectrum Laboratory, Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Bio-Techne, BioSpectra, Corning, FUJIFILM Irvine Scientific, Inc., Dojindo Laboratories, XZL Bio-Technology, Suzhou Yacoo Science, Haihang Chemical, Yunbang Bio-pharmaceutical etc. Top 3 companies occupied about 29% market share.
Read the full market overview
The report provides an overview of the global HEPES market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of HEPES and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents HEPES sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HEPES market size, projected growth trends, production technologies, key applications, and end-use industries.
HEPES Segment by Company
Avantor
Thermo Fisher
Merck
Lonza
Cytiva
Promega Corporation
MP Biomedicals
Spectrum Laboratory
Biological Industries
Cayman Chemical
SERVA Electrophoresis GmbH
Bio-Techne
BioSpectra
Corning
FUJIFILM Irvine Scientific, Inc.
Dojindo Laboratories
XZL Bio-Technology
Suzhou Yacoo Science
Haihang Chemical
Yunbang Bio-pharmaceutical
HEPES Segment by Type
HEPES Powder
HEPES Solution
HEPES Segment by Application
Cell Culture
Protein Extraction
Others
HEPES Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HEPES market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HEPES and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HEPES.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the HEPES market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HEPES industry.
Chapter 3: Detailed analysis of HEPES market competition landscape. Including HEPES manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of HEPES by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of HEPES in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- HEPES Powder
- HEPES Solution
Applications
- Cell Culture
- Protein Extraction
- Others
Companies covered
- Avantor
- Thermo Fisher
- Merck
- Lonza
- Cytiva
- Promega Corporation
- MP Biomedicals
- Spectrum Laboratory
- Biological Industries
- Cayman Chemical
- SERVA Electrophoresis GmbH
- Bio-Techne
- BioSpectra
- Corning
- FUJIFILM Irvine Scientific, Inc.
- Dojindo Laboratories
- XZL Bio-Technology
- Suzhou Yacoo Science
- Haihang Chemical
- Yunbang Bio-pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global HEPES Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global HEPES Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global HEPES Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global HEPES Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global HEPES Market Dynamics
- 2.1 HEPES Industry Trends
- 2.2 HEPES Industry Drivers
- 2.3 HEPES Industry Opportunities and Challenges
- 2.4 HEPES Industry Restraints
3 HEPES Market by Manufacturers
- 3.1 Global HEPES Production Value by Manufacturers (2021-2026)
- 3.2 Global HEPES Production by Manufacturers (2021-2026)
- 3.3 Global HEPES Average Price by Manufacturers (2021-2026)
- 3.4 Global HEPES Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global HEPES Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global HEPES Manufacturers, Product Type & Application
- 3.7 Global HEPES Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global HEPES Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 HEPES Players Market Share by Production Value in 2025
- 3.8.3 2025 HEPES Tier 1, Tier 2, and Tier 3
4 HEPES Market by Type
- 4.1 HEPES Type Introduction
- 4.1.1 HEPES Powder
- 4.1.2 HEPES Solution
- 4.2 Global HEPES Production by Type
- 4.2.1 Global HEPES Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global HEPES Production by Type (2021-2032)
- 4.2.3 Global HEPES Production Market Share by Type (2021-2032)
- 4.3 Global HEPES Production Value by Type
- 4.3.1 Global HEPES Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global HEPES Production Value by Type (2021-2032)
- 4.3.3 Global HEPES Production Value Market Share by Type (2021-2032)
5 HEPES Market by Application
- 5.1 HEPES Application Introduction
- 5.1.1 Cell Culture
- 5.1.2 Protein Extraction
- 5.1.3 Others
- 5.2 Global HEPES Production by Application
- 5.2.1 Global HEPES Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global HEPES Production by Application (2021-2032)
- 5.2.3 Global HEPES Production Market Share by Application (2021-2032)
- 5.3 Global HEPES Production Value by Application
- 5.3.1 Global HEPES Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global HEPES Production Value by Application (2021-2032)
- 5.3.3 Global HEPES Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Avantor
- 6.1.1 Avantor Company Information
- 6.1.2 Avantor Business Overview
- 6.1.3 Avantor HEPES Production, Value and Gross Margin (2021-2026)
- 6.1.4 Avantor HEPES Product Portfolio
- 6.1.5 Avantor Recent Developments
- 6.2 Thermo Fisher
- 6.2.1 Thermo Fisher Company Information
- 6.2.2 Thermo Fisher Business Overview
- 6.2.3 Thermo Fisher HEPES Production, Value and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher HEPES Product Portfolio
- 6.2.5 Thermo Fisher Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck HEPES Production, Value and Gross Margin (2021-2026)
- 6.3.4 Merck HEPES Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza HEPES Production, Value and Gross Margin (2021-2026)
- 6.4.4 Lonza HEPES Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 Cytiva
- 6.5.1 Cytiva Company Information
- 6.5.2 Cytiva Business Overview
- 6.5.3 Cytiva HEPES Production, Value and Gross Margin (2021-2026)
- 6.5.4 Cytiva HEPES Product Portfolio
- 6.5.5 Cytiva Recent Developments
- 6.6 Promega Corporation
- 6.6.1 Promega Corporation Company Information
- 6.6.2 Promega Corporation Business Overview
- 6.6.3 Promega Corporation HEPES Production, Value and Gross Margin (2021-2026)
- 6.6.4 Promega Corporation HEPES Product Portfolio
- 6.6.5 Promega Corporation Recent Developments
- 6.7 MP Biomedicals
- 6.7.1 MP Biomedicals Company Information
- 6.7.2 MP Biomedicals Business Overview
- 6.7.3 MP Biomedicals HEPES Production, Value and Gross Margin (2021-2026)
- 6.7.4 MP Biomedicals HEPES Product Portfolio
- 6.7.5 MP Biomedicals Recent Developments
- 6.8 Spectrum Laboratory
- 6.8.1 Spectrum Laboratory Company Information
- 6.8.2 Spectrum Laboratory Business Overview
- 6.8.3 Spectrum Laboratory HEPES Production, Value and Gross Margin (2021-2026)
- 6.8.4 Spectrum Laboratory HEPES Product Portfolio
- 6.8.5 Spectrum Laboratory Recent Developments
- 6.9 Biological Industries
- 6.9.1 Biological Industries Company Information
- 6.9.2 Biological Industries Business Overview
- 6.9.3 Biological Industries HEPES Production, Value and Gross Margin (2021-2026)
- 6.9.4 Biological Industries HEPES Product Portfolio
- 6.9.5 Biological Industries Recent Developments
- 6.10 Cayman Chemical
- 6.10.1 Cayman Chemical Company Information
- 6.10.2 Cayman Chemical Business Overview
- 6.10.3 Cayman Chemical HEPES Production, Value and Gross Margin (2021-2026)
- 6.10.4 Cayman Chemical HEPES Product Portfolio
- 6.10.5 Cayman Chemical Recent Developments
- 6.11 SERVA Electrophoresis GmbH
- 6.11.1 SERVA Electrophoresis GmbH Company Information
- 6.11.2 SERVA Electrophoresis GmbH Business Overview
- 6.11.3 SERVA Electrophoresis GmbH HEPES Production, Value and Gross Margin (2021-2026)
- 6.11.4 SERVA Electrophoresis GmbH HEPES Product Portfolio
- 6.11.5 SERVA Electrophoresis GmbH Recent Developments
- 6.12 Bio-Techne
- 6.12.1 Bio-Techne Company Information
- 6.12.2 Bio-Techne Business Overview
- 6.12.3 Bio-Techne HEPES Production, Value and Gross Margin (2021-2026)
- 6.12.4 Bio-Techne HEPES Product Portfolio
- 6.12.5 Bio-Techne Recent Developments
- 6.13 BioSpectra
- 6.13.1 BioSpectra Company Information
- 6.13.2 BioSpectra Business Overview
- 6.13.3 BioSpectra HEPES Production, Value and Gross Margin (2021-2026)
- 6.13.4 BioSpectra HEPES Product Portfolio
- 6.13.5 BioSpectra Recent Developments
- 6.14 Corning
- 6.14.1 Corning Company Information
- 6.14.2 Corning Business Overview
- 6.14.3 Corning HEPES Production, Value and Gross Margin (2021-2026)
- 6.14.4 Corning HEPES Product Portfolio
- 6.14.5 Corning Recent Developments
- 6.15 FUJIFILM Irvine Scientific, Inc.
- 6.15.1 FUJIFILM Irvine Scientific, Inc. Company Information
- 6.15.2 FUJIFILM Irvine Scientific, Inc. Business Overview
- 6.15.3 FUJIFILM Irvine Scientific, Inc. HEPES Production, Value and Gross Margin (2021-2026)
- 6.15.4 FUJIFILM Irvine Scientific, Inc. HEPES Product Portfolio
- 6.15.5 FUJIFILM Irvine Scientific, Inc. Recent Developments
- 6.16 Dojindo Laboratories
- 6.16.1 Dojindo Laboratories Company Information
- 6.16.2 Dojindo Laboratories Business Overview
- 6.16.3 Dojindo Laboratories HEPES Production, Value and Gross Margin (2021-2026)
- 6.16.4 Dojindo Laboratories HEPES Product Portfolio
- 6.16.5 Dojindo Laboratories Recent Developments
- 6.17 XZL Bio-Technology
- 6.17.1 XZL Bio-Technology Company Information
- 6.17.2 XZL Bio-Technology Business Overview
- 6.17.3 XZL Bio-Technology HEPES Production, Value and Gross Margin (2021-2026)
- 6.17.4 XZL Bio-Technology HEPES Product Portfolio
- 6.17.5 XZL Bio-Technology Recent Developments
- 6.18 Suzhou Yacoo Science
- 6.18.1 Suzhou Yacoo Science Company Information
- 6.18.2 Suzhou Yacoo Science Business Overview
- 6.18.3 Suzhou Yacoo Science HEPES Production, Value and Gross Margin (2021-2026)
- 6.18.4 Suzhou Yacoo Science HEPES Product Portfolio
- 6.18.5 Suzhou Yacoo Science Recent Developments
- 6.19 Haihang Chemical
- 6.19.1 Haihang Chemical Company Information
- 6.19.2 Haihang Chemical Business Overview
- 6.19.3 Haihang Chemical HEPES Production, Value and Gross Margin (2021-2026)
- 6.19.4 Haihang Chemical HEPES Product Portfolio
- 6.19.5 Haihang Chemical Recent Developments
- 6.20 Yunbang Bio-pharmaceutical
- 6.20.1 Yunbang Bio-pharmaceutical Company Information
- 6.20.2 Yunbang Bio-pharmaceutical Business Overview
- 6.20.3 Yunbang Bio-pharmaceutical HEPES Production, Value and Gross Margin (2021-2026)
- 6.20.4 Yunbang Bio-pharmaceutical HEPES Product Portfolio
- 6.20.5 Yunbang Bio-pharmaceutical Recent Developments
7 Global HEPES Production by Region
- 7.1 Global HEPES Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global HEPES Production by Region (2021-2032)
- 7.2.1 Global HEPES Production by Region (2021-2026)
- 7.2.2 Global HEPES Production Forecast by Region (2027-2032)
- 7.3 Global HEPES Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global HEPES Production Value by Region (2021-2032)
- 7.4.1 Global HEPES Production Value by Region (2021-2026)
- 7.4.2 Global HEPES Production Value by Region (2027-2032)
- 7.5 Global HEPES Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America HEPES Production Value (2021-2032)
- 7.6.2 Europe HEPES Production Value (2021-2032)
- 7.6.3 Asia-Pacific HEPES Production Value (2021-2032)
- 7.6.4 South America HEPES Production Value (2021-2032)
- 7.6.5 Middle East & Africa HEPES Production Value (2021-2032)
8 Global HEPES Consumption by Region
- 8.1 Global HEPES Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global HEPES Consumption by Region (2021-2032)
- 8.2.1 Global HEPES Consumption by Region (2021-2026)
- 8.2.2 Global HEPES Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America HEPES Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America HEPES Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe HEPES Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe HEPES Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific HEPES Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific HEPES Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America HEPES Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America HEPES Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa HEPES Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa HEPES Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 HEPES Value Chain Analysis
- 9.1.1 HEPES Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 HEPES Production Mode & Process
- 9.2 HEPES Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 HEPES Distributors
- 9.2.3 HEPES Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst